B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Degradation of the extracellular matrix

REACTOME PATHWAY
Reactome: R-HSA-147422820 genes25 compounds

The Degradation of the extracellular matrix pathway (Reactome ID: R-HSA-1474228) involves 20 genes and is affected by 25 compounds in the BiohacksAI evidence corpus. Compound-pathway associations are derived from target overlap: a compound is linked to this pathway if it targets ≥2 genes within the pathway.

Genes in this Pathway

ADAM10ADAM17ADAMTS4ADAMTS5CAPN1CMA1CTRB1CTSGCTSLELANEFURINKLK7KLKB1MMP14MMP7NCSTNPRSS1PRSS2PSEN1TPSAB1

Compounds Affecting Degradation of the extracellular matrix

#CompoundTargets HitStudies
1Bortezomib300
2Bisphenol A-Glycidyl Methacrylate197
3Kaempferols300
4egcg300
5piceatannol300
6Sulfaguanidine255
7Dihydroergocristine187
8Gabexate300
9Resveratrol298
10Astemizole Antihistamine drug now withdrawn from280
11Leflunomide297
12Propafenone14
13Thioridazine35
14Progesterone299
15Hexachlorophene300
16Luteolin 5,7,3',4'-tetrahydroxy-flavone,150
17Prednisolone1,000
18Harmaline300
19sp600125117
20Methotrexate289
21Ursolic Acid300
22Diminazene300
23silver sulfadiazine299
24Doxycycline999
25Triamcinolone300

About the Degradation of the extracellular matrix Pathway

The Degradation of the extracellular matrix pathway is catalogued in Reactome (ID: R-HSA-1474228) and involves 20 genes. In the BiohacksAI corpus, 25 compounds have documented interactions with at least 2 genes in this pathway, establishing mechanistic relevance. Key pathway genes include ADAM10, ADAM17, ADAMTS4, ADAMTS5, CAPN1.